Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery

Keuro MedTech

Status: Completed

Conditions: Extracranial Atherosclerosis; AV Fistula; Intracranial Aneurysm; Acute Ischemic Stroke; AVM - Cerebral Arteriovenous Malformation

Treatments: Device: Tarvos Microguidewire

Study type: Observational

Funder types: Industry

Identifiers

NCT07500155

CIP-Reachx-RWD

Details and patient eligibility

About

This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.

Enrollment: 121 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Undertaken a neurovascular surgery procedure including Tarvos microguidewire
• Available images of Tarvos Microguidewire in the neurovascular surgery.

Exclusion criteria

• Disorders of vascular fragility (e.g. Ehlers-Danlos syndrome)
• Prior vascular dissection or injury to the target vessels
• Not meeting the data requirements needed for this study.

Trial design

121 participants in 1 patient group

single arm

Treatment:

Device: Tarvos Microguidewire